Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10607584rdf:typepubmed:Citationlld:pubmed
pubmed-article:10607584lifeskim:mentionsumls-concept:C1335193lld:lifeskim
pubmed-article:10607584lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:10607584pubmed:issue24lld:pubmed
pubmed-article:10607584pubmed:dateCreated2000-2-16lld:pubmed
pubmed-article:10607584pubmed:abstractTextRecent studies have identified the transcription factor Pax5 as a critical determinant of commitment to the B-lymphocyte pathway. Surprisingly, Pax5 appears to achieve this primarily through suppressing alternative haematopoietic lineage fates.lld:pubmed
pubmed-article:10607584pubmed:languageenglld:pubmed
pubmed-article:10607584pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10607584pubmed:citationSubsetIMlld:pubmed
pubmed-article:10607584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10607584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10607584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10607584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10607584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10607584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10607584pubmed:statusMEDLINElld:pubmed
pubmed-article:10607584pubmed:issn0960-9822lld:pubmed
pubmed-article:10607584pubmed:authorpubmed-author:EnverTTlld:pubmed
pubmed-article:10607584pubmed:issnTypePrintlld:pubmed
pubmed-article:10607584pubmed:volume9lld:pubmed
pubmed-article:10607584pubmed:ownerNLMlld:pubmed
pubmed-article:10607584pubmed:authorsCompleteYlld:pubmed
pubmed-article:10607584pubmed:paginationR933-5lld:pubmed
pubmed-article:10607584pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:10607584pubmed:meshHeadingpubmed-meshheading:10607584...lld:pubmed
pubmed-article:10607584pubmed:meshHeadingpubmed-meshheading:10607584...lld:pubmed
pubmed-article:10607584pubmed:meshHeadingpubmed-meshheading:10607584...lld:pubmed
pubmed-article:10607584pubmed:meshHeadingpubmed-meshheading:10607584...lld:pubmed
pubmed-article:10607584pubmed:meshHeadingpubmed-meshheading:10607584...lld:pubmed
pubmed-article:10607584pubmed:meshHeadingpubmed-meshheading:10607584...lld:pubmed
pubmed-article:10607584pubmed:meshHeadingpubmed-meshheading:10607584...lld:pubmed
pubmed-article:10607584pubmed:meshHeadingpubmed-meshheading:10607584...lld:pubmed
pubmed-article:10607584pubmed:meshHeadingpubmed-meshheading:10607584...lld:pubmed
pubmed-article:10607584pubmed:meshHeadingpubmed-meshheading:10607584...lld:pubmed
pubmed-article:10607584pubmed:meshHeadingpubmed-meshheading:10607584...lld:pubmed
pubmed-article:10607584pubmed:meshHeadingpubmed-meshheading:10607584...lld:pubmed
pubmed-article:10607584pubmed:articleTitleB-cell commitment: Pax5 is the deciding factor.lld:pubmed
pubmed-article:10607584pubmed:affiliationSection of Gene Function and Regulation, Chester Beatty Laboratories, Institute of Cancer Research, London, SW3 6JB, UK. tariq@icr.ac.uklld:pubmed
pubmed-article:10607584pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10607584pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10607584lld:pubmed